Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
J-FAPP Study V of low-dose aspirin in familial adenomatous polyposis
jRCTs031210443Active, not recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Jul 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of aspirin in Colonic Adenomatous Polyposis, sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Cumulative rate of colorectal polyps 5.0 mm or larger over 2 years. Started Jul 2022; status: active, not recruiting.
02
Drugs
aspirin
03
Conditions
Colonic Adenomatous Polyposis
Beyond the preview
Go deeper on jRCTs031210443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031210443.